Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Giulia Renda, Ladislav Pecen, Giuseppe Patti, Fabrizio Ricci, Dipak Kotecha, Jolanta M. Siller-Matula, Renate B. Schnabel, Rolf Wachter, Jean-Marc Sellal, Miklos Rohla, Markus Lucerna, Kurt Huber, Freek W. A. Verheugt, Jose Luis Zamorano, Bernd Brüggenjürgen, Harald Darius, Mattias Duytschaever, Jean-Yves Le Heuzey, Richard J. Schilling, Paulus Kirchhof, Raffaele De Caterina

Journal title: Internal and Emergency Medicine

Journal publisher: CEPI-AIM Group

Published year: 2020

DOI identifier: 10.1007/s11739-020-02442-9

ISSN: 1828-0447